305 related articles for article (PubMed ID: 21878675)
1. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.
Gutierrez A; Kentsis A; Sanda T; Holmfeldt L; Chen SC; Zhang J; Protopopov A; Chin L; Dahlberg SE; Neuberg DS; Silverman LB; Winter SS; Hunger SP; Sallan SE; Zha S; Alt FW; Downing JR; Mullighan CG; Look AT
Blood; 2011 Oct; 118(15):4169-73. PubMed ID: 21878675
[TBL] [Abstract][Full Text] [Related]
2. Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.
Ehrlich LA; Yang-Iott K; Bassing CH
Cell Cycle; 2014; 13(19):3076-82. PubMed ID: 25486566
[TBL] [Abstract][Full Text] [Related]
3. Haploinsufficiency of Bcl11b suppresses the progression of ATM-deficient T cell lymphomas.
Pinkney KA; Jiang W; Lee BJ; Loredan DG; Li C; Bhagat G; Zha S
J Hematol Oncol; 2015 Jul; 8():94. PubMed ID: 26219558
[TBL] [Abstract][Full Text] [Related]
4. Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.
Bartram I; Gökbuget N; Schlee C; Heesch S; Fransecky L; Schwartz S; Stuhlmann R; Schäfer-Eckhart K; Starck M; Reichle A; Hoelzer D; Baldus CD; Neumann M
J Hematol Oncol; 2014 Jul; 7():51. PubMed ID: 25023966
[TBL] [Abstract][Full Text] [Related]
5. Role of the transcription factor Bcl11b in development and lymphomagenesis.
Kominami R
Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(3):72-87. PubMed ID: 22450536
[TBL] [Abstract][Full Text] [Related]
6. The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation.
Ha VL; Luong A; Li F; Casero D; Malvar J; Kim YM; Bhatia R; Crooks GM; Parekh C
Leukemia; 2017 Nov; 31(11):2503-2514. PubMed ID: 28232744
[TBL] [Abstract][Full Text] [Related]
7. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells.
Lessel D; Gehbauer C; Bramswig NC; Schluth-Bolard C; Venkataramanappa S; van Gassen KLI; Hempel M; Haack TB; Baresic A; Genetti CA; Funari MFA; Lessel I; Kuhlmann L; Simon R; Liu P; Denecke J; Kuechler A; de Kruijff I; Shoukier M; Lek M; Mullen T; Lüdecke HJ; Lerario AM; Kobbe R; Krieger T; Demeer B; Lebrun M; Keren B; Nava C; Buratti J; Afenjar A; Shinawi M; Guillen Sacoto MJ; Gauthier J; Hamdan FF; Laberge AM; Campeau PM; Louie RJ; Cathey SS; Prinz I; Jorge AAL; Terhal PA; Lenhard B; Wieczorek D; Strom TM; Agrawal PB; Britsch S; Tolosa E; Kubisch C
Brain; 2018 Aug; 141(8):2299-2311. PubMed ID: 29985992
[TBL] [Abstract][Full Text] [Related]
8. BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients.
Kraszewska MD; Dawidowska M; Kosmalska M; Sędek L; Grzeszczak W; Kowalczyk JR; Szczepański T; Witt M;
Blood Cells Mol Dis; 2013 Jan; 50(1):33-8. PubMed ID: 23040356
[TBL] [Abstract][Full Text] [Related]
9. BCL11B is frequently downregulated in HTLV-1-infected T-cells through Tax-mediated proteasomal degradation.
Permatasari HK; Nakahata S; Ichikawa T; Morishita K
Biochem Biophys Res Commun; 2017 Aug; 490(3):1086-1092. PubMed ID: 28669733
[TBL] [Abstract][Full Text] [Related]
10. Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia.
He Z; Liao Z; Chen S; Li B; Yu Z; Luo G; Yang L; Zeng C; Li Y
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e259-e265. PubMed ID: 29749698
[TBL] [Abstract][Full Text] [Related]
11. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
[TBL] [Abstract][Full Text] [Related]
12. The N-Terminal CCHC Zinc Finger Motif Mediates Homodimerization of Transcription Factor BCL11B.
Grabarczyk P; Winkler P; Delin M; Sappa PK; Bekeschus S; Hildebrandt P; Przybylski GK; Völker U; Hammer E; Schmidt CA
Mol Cell Biol; 2018 Mar; 38(5):. PubMed ID: 29203643
[TBL] [Abstract][Full Text] [Related]
13. B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL.
Fang H; Wang W; El Hussein S; Morita K; Beird HC; Mitra A; Loghavi S; Lin P; Jabbour EJ; Khoury JD
Br J Haematol; 2021 Sep; 194(6):1034-1038. PubMed ID: 34402058
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiles in BCL11B-siRNA treated malignant T cells.
Huang X; Shen Q; Chen S; Chen S; Yang L; Weng J; Du X; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
J Hematol Oncol; 2011 May; 4():23. PubMed ID: 21575156
[TBL] [Abstract][Full Text] [Related]
15. Haploinsufficiency and acquired loss of Bcl11b and H2AX induces blast crisis of chronic myelogenous leukemia in a transgenic mouse model.
Nagamachi A; Yamasaki N; Miyazaki K; Oda H; Miyazaki M; Honda Z; Kominami R; Inaba T; Honda H
Cancer Sci; 2009 Jul; 100(7):1219-26. PubMed ID: 19432895
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic isoform switch of tumor suppressor BCL11B in adult T-cell leukemia/lymphoma.
Permatasari HK; Nakahata S; Ichikawa T; Fauzi YR; Kiyonari H; Shide K; Kameda T; Shimoda K; Ono M; Taki T; Taniwaki M; Futakuchi M; Morishita K
Exp Hematol; 2022 Jul; 111():41-49. PubMed ID: 35421541
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia.
Huang X; Chen S; Shen Q; Yang L; Li B; Zhong L; Geng S; Du X; Li Y
J Hematol Oncol; 2010 Nov; 3(1):44. PubMed ID: 21080944
[TBL] [Abstract][Full Text] [Related]
18. Haploinsufficiency of Bcl11b for suppression of lymphomagenesis and thymocyte development.
Kamimura K; Ohi H; Kubota T; Okazuka K; Yoshikai Y; Wakabayashi Y; Aoyagi Y; Mishima Y; Kominami R
Biochem Biophys Res Commun; 2007 Apr; 355(2):538-42. PubMed ID: 17306224
[TBL] [Abstract][Full Text] [Related]
19. Generation of Inducible
Przybylski GK; Korsak D; Iżykowska K; Nowicka K; Zalewski T; Tubacka M; Mosor M; Januszkiewicz-Lewandowska D; Frydrychowicz M; Boruczkowski M; Dworacki G; van den Brandt J; Grabarczyk P; Schmidt CA; Zeng C; Li Y
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563322
[TBL] [Abstract][Full Text] [Related]
20. Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia.
Smits WK; Vermeulen C; Hagelaar R; Kimura S; Vroegindeweij EM; Buijs-Gladdines JGCAM; van de Geer E; Verstegen MJAM; Splinter E; van Reijmersdal SV; Buijs A; Galjart N; van Eyndhoven W; van Min M; Kuiper R; Kemmeren P; Mullighan CG; de Laat W; Meijerink JPP
Cell Rep; 2023 Apr; 42(4):112373. PubMed ID: 37060567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
